Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

タキロン

kyowa Hakko Kirin

KANEKA

Noevir Holdings

Milbon

Chugoku Marine Paints

SATO PHARMACEUTICAL

DAINICHISEIKA COLOR & CHEMICALS MFG.

TOYO INK SC HOLDINGS

Sumitomo Bakelite

AIR WATER

日油

POLA ORBIS HOLDINGS

KOSE

C.Uyemura

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

ROHM

Hitachi Zosen etc.

日本セラミック etc.

日本セラミック etc.

Financial Indicator Details: Milbon (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: Milbon (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Net profit margin (Industry Average)	9.30% (-12.05%)	9.27% (-0.50%)	11.22% (1.53%)	9.72% (-1.67%)	10.55% (3.05%)
C/F margin (Industry Average)	16.04% (-3.31%)	12.32% (8.51%)	15.38% (7.04%)	13.60% (6.35%)	14.73% (8.25%)
ROA (Industry Average)	8.77% (0.52%)	8.78% (1.04%)	10.19% (2.07%)	8.99% (0.06%)	9.55% (2.71%)
ROE (Industry Average)	10.72% (-1.43%)	10.34% (0.03%)	12.08% (2.96%)	10.44% (4.68%)	11.36% (4.57%)
Growth	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Equity growth (Industry Average)	- (-)	6.28% (5.01%)	7.68% (2.61%)	6.86% (-0.40%)	8.75% (8.16%)
Sales growth (Industry Average)	- (-)	2.91% (-2.67%)	3.93% (5.36%)	6.63% (1.07%)	8.87% (2.24%)
Net profit growth (Industry Average)	- (-)	2.58% (203.46%)	25.79% (63.25%)	-7.63% (3.89%)	18.24% (90.38%)
Operating C/F growth (Industry Average)	- (-)	-20.96% (275.10%)	29.76% (35.09%)	-5.71% (-6.09%)	17.93% (138.39%)
Stability	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Capital adequacy (Industry Average)	81.82% (53.80%)	84.91% (54.51%)	84.35% (55.00%)	86.07% (53.59%)	84.14% (56.30%)
Liquidity ratio (Industry Average)	215.22% (217.72%)	294.84% (225.70%)	319.00% (237.55%)	374.44% (239.89%)	325.84% (236.21%)
C/F ratio current liabilities (Industry Average)	105.43% (777.21%)	111.98% (303.31%)	105.38% (434.79%)	104.04% (929.73%)	113.07% (573.30%)
Quick ratio (Industry Average)	137.70% (138.97%)	202.92% (148.85%)	243.72% (156.17%)	291.53% (160.84%)	250.74% (156.81%)
Turnover	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Receivables turnover (Industry Average)	53.34day (83.89day)	52.80day (94.27day)	53.90day (93.96day)	49.44day (97.92day)	47.64day (98.27day)
Inventory turnover (Industry Average)	41.15day (54.45day)	41.06day (52.58day)	39.50day (52.64day)	38.62day (56.59day)	40.07day (58.68day)
Payable turnover (Industry Average)	18.13day (45.01day)	8.63day (49.82day)	7.46day (49.52day)	8.03day (52.10day)	7.67day (51.12day)
Working capita turnover (Industry Average)	76.36day (93.32day)	85.23day (97.02day)	85.94day (97.08day)	80.03day (102.41day)	80.04day (105.83day)
Stock etc.	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Market Value growth (Industry Average)	- (-)	18.61% (34.57%)	10.67% (1.49%)	15.65% (-3.85%)	80.89% (21.16%)
Dividend Yield (Industry Average)	2.82% (3.20%)	2.33% (1.93%)	2.53% (2.17%)	2.40% (2.45%)	1.35% (2.07%)
PER (Industry Average)	13.91% (25.22%)	16.08% (23.06%)	14.15% (16.22%)	17.72% (29.19%)	27.11% (16.58%)
PBR (Industry Average)	1.49% (0.86%)	1.66% (1.06%)	1.71% (1.04%)	1.85% (0.95%)	3.08% (1.08%)
PCFR (Industry Average)	8.06% (7.18%)	12.10% (9.23%)	10.32% (-2.43%)	12.66% (9.50%)	19.42% (7.56%)
PSR (Industry Average)	1.29% (0.77%)	1.49% (0.88%)	1.58% (1.10%)	1.72% (0.90%)	2.86% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Net profit margin (Industry Average)	9.64% (-27.66%)	10.52% (-4.34%)	11.74% (-5.37%)	10.05% (-10.69%)	10.98% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	8.89% (0.52%)	9.64% (0.92%)	10.26% (1.42%)	8.90% (-0.27%)	9.72% (1.53%)
ROE (Industry Average)	10.81% (-0.84%)	11.25% (-0.46%)	12.08% (1.81%)	10.26% (3.42%)	11.29% (2.62%)
Growth	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Equity growth (Industry Average)	- (-)	7.62% (3.64%)	8.09% (3.03%)	6.71% (0.04%)	7.46% (3.91%)
Sales growth (Industry Average)	- (-)	2.64% (-3.48%)	3.96% (6.70%)	5.86% (0.75%)	8.30% (-1.74%)
Net profit growth (Industry Average)	- (-)	11.97% (166.48%)	16.02% (43.48%)	-9.30% (-47.04%)	18.25% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Capital adequacy (Industry Average)	82.20% (56.79%)	85.72% (57.65%)	85.00% (57.17%)	86.73% (55.93%)	86.03% (57.57%)
Liquidity ratio (Industry Average)	201.50% (337.22%)	286.11% (276.75%)	312.14% (266.94%)	354.19% (314.47%)	328.95% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	129.09% (167.28%)	198.93% (183.78%)	244.01% (174.83%)	280.41% (228.06%)	255.87% (169.77%)
Turnover	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Receivables turnover (Industry Average)	55.54day (87.55day)	54.03day (98.39day)	55.97day (95.88day)	53.34day (98.58day)	52.24day (67.18day)
Inventory turnover (Industry Average)	39.26day (50.17day)	38.79day (48.43day)	36.03day (47.43day)	34.59day (50.67day)	35.44day (38.21day)
Payable turnover (Industry Average)	18.36day (45.70day)	8.76day (51.63day)	7.57day (51.13day)	8.16day (53.57day)	7.89day (34.24day)
Working capita turnover (Industry Average)	76.44day (92.02day)	84.06day (95.19day)	84.43day (92.19day)	79.77day (95.69day)	79.79day (71.15day)
Stock etc.	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Market Value growth (Industry Average)	- (-)	18.61% (34.46%)	10.67% (3.11%)	15.65% (-3.30%)	80.89% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	13.59% (34.12%)	14.39% (27.80%)	13.73% (13.58%)	17.51% (22.26%)	26.79% (26.42%)
PBR (Industry Average)	1.47% (0.97%)	1.62% (1.21%)	1.65% (1.17%)	1.79% (1.08%)	3.02% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	1.31% (3.42%)	1.51% (4.34%)	1.61% (3.67%)	1.76% (4.37%)	2.94% (10.14%)

Financial Indicator Details: Milbon

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Profitability
Net profit margin	9.30%	9.27%	11.22%	9.72%	10.55%
C/F margin	16.04%	12.32%	15.38%	13.60%	14.73%
ROA	8.77%	8.78%	10.19%	8.99%	9.55%
ROE	10.72%	10.34%	12.08%	10.44%	11.36%
Recurring margin	16.17%	16.84%	17.27%	17.06%	17.03%
EBIT margin	15.54%	16.24%	19.22%	16.35%	16.92%
EBITDA margin	21.36%	21.35%	24.17%	20.70%	20.63%
NOPAT margin	9.32%	9.74%	11.53%	9.81%	10.15%
Sales SG rates	36.34%	34.16%	33.64%	32.22%	32.12%
Sales SG&A rates	46.57%	47.71%	47.88%	49.56%	49.82%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	5.81%	5.11%	4.94%	4.35%	3.70%
Capital expenditures net sales ratio	-7.67%	-3.10%	-1.48%	-3.14%	-5.53%
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Growth
Growth rate of cash	-	60.43%	90.03%	19.42%	12.84%
Equity growth	-	6.28%	7.68%	6.86%	8.75%
Total assets growth	-	2.40%	8.39%	4.73%	11.23%
Sales growth	-	2.91%	3.93%	6.63%	8.87%
Net profit growth	-	2.58%	25.79%	-7.63%	18.24%
Operating C/F growth	-	-20.96%	29.76%	-5.71%	17.93%
Recurring profit growth	-	7.20%	6.55%	5.35%	8.69%
EBIT growth	-	7.52%	23.03%	-9.28%	12.67%
EBITDA growth	-	2.87%	17.62%	-8.64%	8.48%
NOPAT growth	-	7.52%	23.03%	-9.28%	12.67%
Operating expenses growth	-	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Stability
Capital adequacy	81.82%	84.91%	84.35%	86.07%	84.14%
Liquidity ratio	215.22%	294.84%	319.00%	374.44%	325.84%
C/F ratio current liabilities	105.43%	111.98%	105.38%	104.04%	113.07%
Quick ratio	137.70%	202.92%	243.72%	291.53%	250.74%
Fixed ratio	63.89%	58.20%	51.17%	46.78%	47.02%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-47.83%	-25.21%	-9.66%	-23.09%	-37.58%
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Turnover
Cash turnover	31.69day	49.40day	90.32day	101.16day	104.85day
Receivables turnover	53.34day	52.80day	53.90day	49.44day	47.64day
Inventory turnover	41.15day	41.06day	39.50day	38.62day	40.07day
Fixed assets turnover	202.38day	190.38day	173.43day	158.91day	159.54day
Total asset turnover	387.14day	385.21day	401.75day	394.60day	403.16day
Payable turnover	18.13day	8.63day	7.46day	8.03day	7.67day
Capital turnover	38.04day	36.96day	35.56day	33.35day	30.63day
Equity turnover	316.76day	327.11day	338.91day	339.65day	339.26day
Working capita turnover	76.36day	85.23day	85.94day	80.03day	80.04day
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Balance sheet
Cash etc.	¥ 1 B	¥ 2 B	¥ 5 B	¥ 6 B	¥ 6 B
Accounts receivable-trade	¥ 2 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 3 B
Other Current Assets	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 6 B
Current Assets	¥ 6 B	¥ 8 B	¥ 10 B	¥ 11 B	¥ 12 B
Tangible Assets	¥ 10 B	¥ 10 B	¥ 9 B	¥ 9 B	¥ 10 B
Intangible Assets	¥ 318 M	¥ 451 M	¥ 512 M	¥ 526 M	¥ 481 M
Investment etc.	¥ 2 B	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B
Total Assets	¥ 20 B	¥ 20 B	¥ 22 B	¥ 23 B	¥ 26 B
Current Liabilities	¥ 3 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Fixed Liabilities	¥ 453 M	¥ 418 M	¥ 205 M	¥ 197 M	¥ 201 M
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 16 B	¥ 17 B	¥ 19 B	¥ 20 B	¥ 22 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Capital surplus etc.	¥ 14 B	¥ 15 B	¥ 17 B	¥ 18 B	¥ 20 B
Liabilities and net assets	¥ 20 B	¥ 20 B	¥ 22 B	¥ 23 B	¥ 26 B
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Income statement
Sales	¥ 19 B	¥ 19 B	¥ 20 B	¥ 21 B	¥ 23 B
Cost of Sales	¥ 6 B	¥ 6 B	¥ 6 B	¥ 7 B	¥ 7 B
Gross profit	¥ 12 B	¥ 13 B	¥ 13 B	¥ 14 B	¥ 16 B
Other income	¥ 161 M	¥ 126 M	¥ 615 M	¥ 120 M	¥ 159 M
SG&A	¥ 8 B	¥ 9 B	¥ 9 B	¥ 10 B	¥ 11 B
Other expenses	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B
Net income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Operating income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Ordinary Income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
EBITDA	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Income before income taxes	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
Depreciation	¥ 1 B	¥ 1 B	¥ 1 B	¥ 952 M	¥ 882 M
R&D expenses	-	-	-	-	-
Income taxes	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Cash flow statement
Operating CF	¥ 3 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 3 B
Investment CF	¥ -1 B	¥ -727 M	¥ 101 M	¥ -1 B	¥ -1 B
Financial CF	¥ -725 M	¥ -688 M	¥ -836 M	¥ -910 M	¥ -1 B
Foreign Exchange Effects	¥ -18 M	¥ -13 M	¥ -16 M	¥ -3 M	¥ 52 M
Net Change in Cash	¥ 655 M	¥ 1 B	¥ 2 B	¥ 556 M	¥ 977 M
Free CF	¥ 1 B	¥ 1 B	¥ 3 B	¥ 1 B	¥ 2 B
Capital expenditures	¥ -1 B	¥ -613 M	¥ -305 M	¥ -687 M	¥ -1 B
Cash dividends paid	¥ -701 M	¥ -688 M	¥ -825 M	¥ -908 M	¥ -922 M
Repayment loans	¥ -23 M	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -701 M	¥ -689 M	¥ -827 M	¥ -909 M	¥ -923 M
Net income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Purchase of treasury stock	¥ -577 K	¥ 44 K	¥ -10 M	¥ -2 M	¥ -465 M
Other Change in Stockholders Equity	¥ -1 K	¥ -2 K	¥ -1 K	-	¥ 1 K
Other Change in Net Assets	¥ -87 M	¥ -96 M	¥ -106 M	¥ 91 M	¥ 654 M
Net Change in Net Assets	¥ 995 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B

Financial Indicator Details: Milbon

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Profitability
Net profit margin	9.64%	10.52%	11.74%	10.05%	10.98%
C/F margin	-	-	-	-	-
ROA	8.89%	9.64%	10.26%	8.90%	9.72%
ROE	10.81%	11.25%	12.08%	10.26%	11.29%
Recurring margin	16.70%	18.06%	17.91%	17.57%	18.35%
EBIT margin	16.06%	17.45%	19.86%	16.86%	17.43%
EBITDA margin	17.76%	19.35%	22.07%	18.86%	19.17%
NOPAT margin	9.64%	10.47%	11.92%	10.11%	10.46%
Sales SG rates	37.17%	34.81%	34.52%	33.13%	32.94%
Sales SG&A rates	45.15%	45.95%	46.30%	48.10%	47.57%
Sales R&D expenses rates	4.04%	4.30%	4.30%	4.08%	4.18%
Sales depreciation rates	1.69%	1.90%	2.20%	1.99%	1.73%
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Growth
Growth rate of cash	-	83.83%	108.51%	9.27%	4.07%
Equity growth	-	7.62%	8.09%	6.71%	7.46%
Total assets growth	-	3.20%	9.00%	4.58%	8.34%
Sales growth	-	2.64%	3.96%	5.86%	8.30%
Net profit growth	-	11.97%	16.02%	-9.30%	18.25%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	11.00%	3.12%	3.80%	13.11%
EBIT growth	-	11.50%	18.33%	-10.15%	12.00%
EBITDA growth	-	11.84%	18.56%	-9.56%	10.08%
NOPAT growth	-	11.50%	18.33%	-10.15%	12.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Stability
Capital adequacy	82.20%	85.72%	85.00%	86.73%	86.03%
Liquidity ratio	201.50%	286.11%	312.14%	354.19%	328.95%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	129.09%	198.93%	244.01%	280.41%	255.87%
Fixed ratio	62.49%	56.37%	49.43%	44.89%	43.36%
D/E ratio	-	-	-	-	-
Loan to Value Ratio	-	-	-	-	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Turnover
Cash turnover	24.56day	43.99day	88.24day	91.08day	87.53day
Receivables turnover	55.54day	54.03day	55.97day	53.34day	52.24day
Inventory turnover	39.26day	38.79day	36.03day	34.59day	35.44day
Fixed assets turnover	203.38day	192.33day	175.36day	160.54day	153.85day
Total asset turnover	395.86day	398.03day	417.32day	412.28day	412.41day
Payable turnover	18.36day	8.76day	7.57day	8.16day	7.89day
Capital turnover	38.53day	37.53day	36.10day	34.10day	31.49day
Equity turnover	325.42day	341.20day	354.74day	357.59day	354.80day
Working capita turnover	76.44day	84.06day	84.43day	79.77day	79.79day
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Balance sheet
Cash etc.	¥ 1 B	¥ 2 B	¥ 4 B	¥ 5 B	¥ 5 B
Accounts receivable-trade	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Other Current Assets	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B
Current Assets	¥ 6 B	¥ 7 B	¥ 10 B	¥ 10 B	¥ 11 B
Tangible Assets	¥ 10 B	¥ 10 B	¥ 9 B	¥ 9 B	¥ 9 B
Intangible Assets	¥ 300 M	¥ 447 M	¥ 508 M	¥ 523 M	¥ 453 M
Investment etc.	¥ 3 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 4 B
Total Assets	¥ 20 B	¥ 21 B	¥ 23 B	¥ 24 B	¥ 26 B
Current Liabilities	¥ 3 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Fixed Liabilities	¥ 435 M	¥ 402 M	¥ 191 M	¥ 185 M	¥ 189 M
Liabilities with interest	-	-	-	-	-
Net Assets	¥ 16 B	¥ 18 B	¥ 19 B	¥ 20 B	¥ 22 B
Capital stock	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Capital surplus etc.	¥ 14 B	¥ 16 B	¥ 17 B	¥ 18 B	¥ 20 B
Liabilities and net assets	¥ 20 B	¥ 21 B	¥ 23 B	¥ 24 B	¥ 26 B
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Income statement
Sales	¥ 18 B	¥ 19 B	¥ 20 B	¥ 21 B	¥ 23 B
Cost of Sales	¥ 7 B	¥ 6 B	¥ 6 B	¥ 7 B	¥ 7 B
Gross profit	¥ 11 B	¥ 12 B	¥ 13 B	¥ 14 B	¥ 15 B
Other income	¥ 151 M	¥ 117 M	¥ 607 M	¥ 116 M	¥ 141 M
SG&A	¥ 8 B	¥ 8 B	¥ 9 B	¥ 10 B	¥ 11 B
Other expenses	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 2 B
Net income	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Operating income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B
Ordinary Income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B
EBITDA	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B
Income before income taxes	¥ 3 B	¥ 3 B	¥ 4 B	¥ 3 B	¥ 4 B
Depreciation	¥ 321 M	¥ 370 M	¥ 446 M	¥ 427 M	¥ 401 M
R&D expenses	¥ 766 M	¥ 838 M	¥ 870 M	¥ 873 M	¥ 969 M
Income taxes	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-12-20	2010-12-20	2011-12-20	2012-12-20	2013-12-20
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -701 M	¥ -689 M	¥ -827 M	¥ -909 M	¥ -923 M
Net income	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Purchase of treasury stock	¥ -577 K	¥ 44 K	¥ -10 M	¥ -2 M	¥ -465 M
Other Change in Stockholders Equity	¥ -2 K	¥ -1 K	¥ -2 K	-	-
Other Change in Net Assets	¥ -22 M	¥ -69 M	¥ -65 M	¥ 77 M	¥ 406 M
Net Change in Net Assets	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Milbon (Annual )

Statement Type

Annual : Milbon

First quarter : Milbon

Second quarter : Milbon

Third quarter : Milbon

Analysis Menu

Outline : Milbon

Statement : Milbon

Rating : Milbon

Indicator : Milbon

Download : Milbon

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
Milbon	4919	TSE 1st	Chemicals	12	Annual	AAA

Related Company

日油 (Sales ¥ 148 B)

KOSE (Sales ¥ 170 B)

TOAGOSEI CO (Sales ¥ 148 B)

日本新薬 (Sales ¥ 69 B)

SAKATA INX (Sales ¥ 123 B)

Chugoku Marine Paints (Sales ¥ 83 B)

参天製薬 (Sales ¥ 119 B)

SATO PHARMACEUTICAL (Sales ¥ 38 B)

POLA ORBIS HOLDINGS (Sales ¥ 180 B)

JSP (Sales ¥ 96 B)

Sumitomo Bakelite (Sales ¥ 183 B)

kyowa Hakko Kirin (Sales ¥ 333 B)

NITTO FC (Sales ¥ 18 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .